International drugs cut prescription expenses for self-insured employers
Published
4 Min Read
More From Employee Benefit News
Forging stronger broker-TPA partnerships
Collaboration between employers, brokers and third-party administrators will be essential to developing customized, cost-effective and employee-friendly solutions.
Employers face a new GLP-1 question: Are the drugs worth it?
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
Healthcare costs are forcing employers to reconsider their benefits strategy
Employers are under pressure to keep benefits competitive while controlling costs, driving new scrutiny of PBMs, hospital prices and GLP-1 coverage for 2027.
Benefits Think Rewriting the PBM playbook: Exposing hidden costs and empowering plan sponsors
Part one of this two-part series looks at the background, transparency solutions and how to understand PBM profitability.
Is employer health insurance at risk? A veteran benefits lobbyist weighs in
As Washington revisits the tax-favored status of health benefits, a longtime policy expert explains why replacing group plans could cost far more.
